D
BioHarvest Sciences Inc.
CNVCF
OTC PK
$0.2798 $0.00983.63% Volume85,779 08/12/2022 3:57PM Eastern Quotes delayed
Recommendation
Prev Close
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 4/29/2022Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 4/29/2022 due to a large increase in the growth index and solvency index. EBIT increased 55.87% from -$2.68M to -$1.18M, earnings per share increased from -$0.007 to -$0.0039, and total revenue increased 13.35% from $644 to $730.
D
Sell 4/20/2022Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and growth index. Earnings per share declined from $0.0042 to -$0.007, and EBIT declined 12.17% from -$2.39M to -$2.68M.
D
Sell 11/23/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell 11/8/2021Downgrade
BioHarvest Sciences Inc. (CNVCF) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index.
D
Sell 6/1/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D from D- on 6/1/2021 due to an increase in the growth index and total return index. Total revenue increased 19.47% from $262 to $313, EBIT increased 6.26% from -$2.38M to -$2.23M, and operating cash flow increased 3.45% from -$1.25M to -$1.2M.
D
Sell 2/1/2021Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to D- from E+ on 2/1/2021 due to a noticeable increase in the growth index, solvency index and total return index. Debt to equity declined from -0.01 to -0.03, the quick ratio increased from 1.01 to 2.42, and total revenue increased 35.9% from $39 to $53.
E
Sell 11/2/2020Upgraded
BioHarvest Sciences Inc. (CNVCF) was upgraded to E+ from E on 11/2/2020 due to an increase in the total return index.
E
Sell 8/28/2020None
BioHarvest Sciences Inc. (CNVCF) was downgraded to E from U on 08/28/2020.
Weiss Ratings